CVS Health Corp (NYSE:CVS) reported a strong finish to 2024, surpassing earnings and revenue forecasts for the fourth quarter. The company posted earnings per share (EPS) of $1.19, beating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback